ClinicalTrials.gg
CompletedNCT07941869JPMRUpdated Nov 17, 2026

Effectiveness of Jacobson's Progressive Muscle Relaxation Technique (JPMR) on Fracture-Related Anxiety in Adult Patients With Long Bone Fractures in the Emergency Department

An interventional study of Jacobson's Progressive Muscle Relaxation Technique (JPMR) and Routine Emergency Department Care in Long Bone Fractures and Anxiety, sponsored by Dubai Health. Completed at 1 site in United Arab Emirates. Open to participants aged 25 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by Dubai Health · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Dec 2025, registered Oct 2026).
Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Non-randomized
Ages
25 Years to 59 Years
Sex
All
01

Study summary

Long bone fractures can cause significant anxiety in adult patients attending the Emergency Department. Anxiety may occur while patients wait for further treatment, admission, or surgery.

This study evaluated the effectiveness of Jacobson's Progressive Muscle Relaxation Technique (JPMR) in reducing fracture-related anxiety among adult patients with long bone fractures in the Emergency Department of Rashid Hospital Trauma Center, Dubai, United Arab Emirates.

The study used a non-randomized controlled design. Eligible adult patients were allocated to an intervention group or a control group. Participants in the intervention group received Jacobson's Progressive Muscle Relaxation Technique in addition to routine care, while participants in the control group received routine care.

Fracture-related anxiety was assessed using the Fracture-Specific Anxiety Scale (FSAS). Pain was also assessed using a Visual Analogue Scale (VAS).

The study compared anxiety levels before and after the intervention and between the intervention and control groups. The findings were intended to help determine whether JPMR may be a useful supportive intervention for managing fracture-related anxiety in the Emergency Department.

Read the detailed description

The study was conducted in the Emergency Department of Rashid Hospital Trauma Center, Dubai, United Arab Emirates. It investigated Jacobson's Progressive Muscle Relaxation Technique as a supportive intervention for fracture-related anxiety among adults with long bone fractures.

The study employed a prospective, non-randomized controlled design. Eligible participants were adults aged 25-59 years with long bone fractures who met the study eligibility criteria and provided informed consent. Patients with cognitive impairment, psychiatric conditions, or a requirement for immediate surgery were excluded, according to the approved protocol.

Participants in the intervention group received Jacobson's Progressive Muscle Relaxation Technique in addition to routine care. Participants in the control group received routine care. Anxiety was measured using the Fracture-Specific Anxiety Scale (FSAS), and pain was assessed using a Visual Analogue Scale (VAS).

The study evaluated changes in fracture-related anxiety and compared outcomes between the two groups. The relationship between pain and anxiety was also examined.

The study received the required ethical approvals before it was conducted. The study findings may contribute to understanding the potential role of relaxation techniques in supporting patients with long bone fractures during their Emergency Department stay.

02

Conditions studied

  • Long Bone Fractures
  • Anxiety

Browse trials for

Keywords

  • Jacobson's Progressive Muscle Relaxation
  • Fracture-Related Anxiety
  • Long Bone Fractures
  • Emergency Department
  • Anxiety
  • Pain
03

In context

Anxiety Disorders Unverified

7,231 studies on the registry are indexed under Anxiety Disorders; 1,686 are open to participants now.

This study's enrollment of 70 is below the median of 80 across 6,085 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Dubai Health is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
25 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 25 to 59 years.
  • Patients diagnosed with one or more long bone fractures (femur, tibia, fibula, humerus, radius, or ulna) in the Emergency Department (clinically confirmed).
  • Patients with a stable medical condition.
  • Able to participate in non-pharmacological interventions such as Jacobson's Progressive Muscle Relaxation Technique.
  • Able to understand and communicate in English or Arabic, and to provide and respond to anxiety assessment tools.

Exclusion criteria

EXCLUSION CRITERIA:

  • Patients with cognitive impairments or conditions that affect the ability to understand the procedure or complete the anxiety assessment.
  • Patients with diagnosed psychiatric conditions or currently under psychiatric medication.
  • Patients who are undergoing or are planned to undergo immediate surgery for the fracture.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    JPMR + Routine Care

    Participants received Jacobson's Progressive Muscle Relaxation Technique (JPMR) in addition to routine care in the Emergency Department.

    Behavioral: Jacobson's Progressive Muscle Relaxation Technique (JPMR)

  • Active comparator
    Routine Care Control

    Participants received routine care in the Emergency Department without the JPMR intervention.

    Other: Routine Emergency Department Care

Interventions

  • BehavioralJacobson's Progressive Muscle Relaxation Technique (JPMR)

    Jacobson's Progressive Muscle Relaxation Technique was provided to participants in the intervention group in addition to routine Emergency Department care, according to the approved study protocol.

  • OtherRoutine Emergency Department Care

    Participants in the control group received routine Emergency Department care without the Jacobson's Progressive Muscle Relaxation Technique (JPMR) intervention.

06

What researchers measure

Primary outcomes

  1. Change in Fracture-Related Anxiety Scores Measured Using the Fracture-Specific Anxiety Scale (FSAS)

    Fracture-related anxiety was assessed using the Fracture-Specific Anxiety Scale (FSAS), a 10-item scale with each item scored from 0 to 4, giving a total score of 0-40. Anxiety scores were measured before and after the intervention and compared between the JPMR intervention group and the routine care control group. Higher scores indicate greater anxiety.

    Time frame: Baseline before the intervention and immediately after the 20-30-minute JPMR session; the control group was reassessed after 30 minutes.

Secondary outcomes

  1. Change in Pain Scores Measured Using the Visual Analogue Scale (VAS)

    Pain intensity was assessed using the Visual Analogue Scale (VAS) before and after the intervention. Changes in pain scores were compared between the JPMR intervention group and the routine care control group.

    Time frame: Baseline before the intervention and immediately after the 20-30-minute JPMR session; the control group was reassessed after 30 minutes.

07

Study locations

1 site
  • Rashid Hospital
    Dubai, إمارة دبيّ, United Arab Emirates
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — Individual participant data will not be shared with other researchers because of participant confidentiality and data privacy considerations. Only aggregate study findings may be reported in publications.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2025 to primary completion in Jan 2026, 1 month.

Of 3,859 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 1 month is below that.

Counting every sponsor, half of 3,962 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 17, 2026
StartActual
Dec 18, 2025
Primary completionActual
Jan 29, 2026
CompletionActual
Feb 25, 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07941869
Lead sponsor
Dubai Health
Responsible party
Sponsor
First posted
Nov 17, 2026
Start date
Dec 18, 2025
Primary completion
Jan 29, 2026
Completion
Feb 25, 2026
Last update
Nov 17, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion